TY - JOUR
T1 - Blood cholesterol in late-life and cognitive decline
T2 - A longitudinal study of the Chinese elderly
AU - Ma, Chaoran
AU - Yin, Zhaoxue
AU - Zhu, Pengfei
AU - Luo, Jiesi
AU - Shi, Xiaoming
AU - Gao, Xiang
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/3/7
Y1 - 2017/3/7
N2 - Background: Previous studies regarding the lipid-cognition relation in older adults are limited and have generated mixed results. We thus examined whether higher blood cholesterol concentrations were associated with faster cognitive decline in a community-based longitudinal study of Chinese elderly. Methods: The study included 1,159 Chinese adults aged over 60 years (women: 48.7%, mean age: 79.4 years), who were free of dementia, Parkinson disease and stroke at the baseline. Blood concentrations of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), were assessed at the baseline. Global cognitive functions were assessed using the Chinese Mini-Mental State Examination (MMSE) at in 2009, 2012 and 2014. Association between blood cholesterol and repeated cognitive function was analyzed with linear mixed models, adjusting for sociodemographic information, behavior and lifestyle, depression symptoms, physical examination, hypertension, and laboratory indexes. Results: Higher baseline TC and LDL-C concentrations were significantly associated with greater cognitive decline. Adjusted mean difference in cognitive decline rate, comparing two extreme quartiles, was 0.28 points (MMSE score) per year (95% confident interval (CI): -0.54,-0.02; P-trend = 0.005) for TC and 0.42 points per year (95% CI: -0.69, -0.16; P-trend = 0.006) for LDL-C. In a subgroup analysis, the associations between all lipids and cognitive decline appeared to be more pronounced among individuals aged 100 years or older (n = 90), relative to others. Conclusions: Higher blood concentrations of TC and LDL-C in late-life were associated with faster global cognitive decline.
AB - Background: Previous studies regarding the lipid-cognition relation in older adults are limited and have generated mixed results. We thus examined whether higher blood cholesterol concentrations were associated with faster cognitive decline in a community-based longitudinal study of Chinese elderly. Methods: The study included 1,159 Chinese adults aged over 60 years (women: 48.7%, mean age: 79.4 years), who were free of dementia, Parkinson disease and stroke at the baseline. Blood concentrations of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), were assessed at the baseline. Global cognitive functions were assessed using the Chinese Mini-Mental State Examination (MMSE) at in 2009, 2012 and 2014. Association between blood cholesterol and repeated cognitive function was analyzed with linear mixed models, adjusting for sociodemographic information, behavior and lifestyle, depression symptoms, physical examination, hypertension, and laboratory indexes. Results: Higher baseline TC and LDL-C concentrations were significantly associated with greater cognitive decline. Adjusted mean difference in cognitive decline rate, comparing two extreme quartiles, was 0.28 points (MMSE score) per year (95% confident interval (CI): -0.54,-0.02; P-trend = 0.005) for TC and 0.42 points per year (95% CI: -0.69, -0.16; P-trend = 0.006) for LDL-C. In a subgroup analysis, the associations between all lipids and cognitive decline appeared to be more pronounced among individuals aged 100 years or older (n = 90), relative to others. Conclusions: Higher blood concentrations of TC and LDL-C in late-life were associated with faster global cognitive decline.
UR - http://www.scopus.com/inward/record.url?scp=85014595136&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014595136&partnerID=8YFLogxK
U2 - 10.1186/s13024-017-0167-y
DO - 10.1186/s13024-017-0167-y
M3 - Article
C2 - 28270179
AN - SCOPUS:85014595136
SN - 1750-1326
VL - 12
JO - Molecular Neurodegeneration
JF - Molecular Neurodegeneration
IS - 1
M1 - 24
ER -